Apixaban and Venous pressure jugular increased - a phase IV clinical study of FDA data

Summary:

Venous pressure jugular increased is reported as a side effect among people who take Apixaban (apixaban), especially for people who are female, 60+ old, also take Calcium, and have Asthma.

The phase IV clinical study analyzes which people have Venous pressure jugular increased when taking Apixaban. It is created by eHealthMe based on reports of 60,044 people who have side effects when taking Apixaban from the FDA, and is updated regularly.

What is Apixaban?

Apixaban has active ingredients of apixaban. It is often used in blood clots. eHealthMe is studying from 60,351 Apixaban users. Check the latest studies of Apixaban.

What is Venous pressure jugular increased?

Venous pressure jugular increased is found to be associated with 95 drugs and 207 conditions by eHealthMe. Check the latest studies of Venous pressure jugular increased.

On Jul, 08, 2026

60,044 people reported to have side effects when taking Apixaban.
Among them, 40 people (0.07%) have Venous pressure jugular increased.

Could Apixaban cause Venous pressure jugular increased?

Among these 40 people:

What is the gender of people who have Venous pressure jugular increased when taking Apixaban? *

female: 95 %
male: 5 %

What is the age of people who have Venous pressure jugular increased when taking Apixaban? *

What are other drugs people take besides Apixaban? *

What are other side effects people have besides Venous pressure jugular increased? *

Dyspnea (difficult or laboured breathing): 39 people, 97.50%
Oedema Peripheral (superficial swelling): 39 people, 97.50%
Pain In Extremity: 38 people, 95.00%
Bundle Branch Block Left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle): 38 people, 95.00%
Dyspnea Exertional: 38 people, 95.00%
Cardiac Failure Congestive: 38 people, 95.00%
Joint Swelling: 38 people, 95.00%
Pulmonary Oedema (fluid accumulation in the lungs): 38 people, 95.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 38 people, 95.00%
Productive Cough: 37 people, 92.50%

What are the existing conditions these people have? *

Asthma: 37 people, 92.50%
Cardiac Amyloidosis (protein deposition in heart): 2 people, 5.00%
Osteoporosis (bones weak and more likely to break): 1 person, 2.50%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Apixaban and have Venous pressure jugular increased?

- Check whether Venous pressure jugular increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Apixaban:

Apixaban (60,351 reports)

Browse all side effects of Apixaban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Venous pressure jugular increased:

Venous pressure jugular increased (95 drugs)

Browse all the conditions that are associated with Venous pressure jugular increased:

Venous pressure jugular increased (207 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on apixaban (the active ingredients of Apixaban) and Apixaban (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.